title: Risk of malignancy in 22q11.2 deletion syndrome.
abstract: 22q11.2DS is a significant health problem because of its fairly high incidence. It is relevant to be vigilant regarding the diagnosis of cancer amongst 22q11.2 patients as there might be an increased risk, especially amongst patients with the 22q11.2 distal deletion syndrome.
authors.affiliation: University of Antwerp Antwerp Belgium.
authors.forename: Toer
authors.initials: T
authors.lastname: Stevens
authors.affiliation: Department of Pediatric Hematology Oncology UZ Brussel Brussels Belgium.
authors.forename: Jutte
authors.initials: J
authors.lastname: van der Werff Ten Bosch
authors.affiliation: Centre for Medical Genetics, Reproduction and Genetics Reproduction Genetics and Regenerative Medicine UZ Brussel Brussels Belgium.
authors.forename: Marjan
authors.initials: M
authors.lastname: De Rademaeker
authors.affiliation: Centre for Medical Genetics, Reproduction and Genetics Reproduction Genetics and Regenerative Medicine UZ Brussel Brussels Belgium.
authors.forename: Ann
authors.initials: A
authors.lastname: Van Den Bogaert
authors.affiliation: Department of Pediatric Hematology Oncology UZ Brussel Brussels Belgium; Department of Pediatrics Queen Paola Children's Hospital Antwerp Belgium.
authors.forename: Machiel
authors.identifier: 0000-0003-2828-6226
authors.initials: M
authors.lastname: van den Akker
keywords: Chromosome 22q11.2 Deletion Syndrome; Digeorge syndrome; Velocardiofacial syndrome; malignancy; pineoblastoma